These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2406298)

  • 21. Effects of bepridil on exercise tolerance in chronic stable angina: a double-blind, randomized, placebo-controlled, crossover trial.
    Hill JA; O'Brien JT; Scott E; Conti CR; Pepine CJ
    Am J Cardiol; 1984 Mar; 53(6):679-83. PubMed ID: 6367414
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The comparative efficacy of nicardipine and nifedipine in stenocardia patients].
    Slastnikova ID; Martsevich SIu; Simkhaev LS; Metelitsa VI
    Ter Arkh; 1990; 62(10):142-5. PubMed ID: 2084879
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diltiazem, nifedipine, and their combination in patients with stable angina pectoris: effects on angina, exercise tolerance, and the ambulatory electrocardiographic ST segment.
    Frishman W; Charlap S; Kimmel B; Teicher M; Cinnamon J; Allen L; Strom J
    Circulation; 1988 Apr; 77(4):774-86. PubMed ID: 3280158
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Addition of zatebradine, a direct sinus node inhibitor, provides no greater exercise tolerance benefit in patients with angina taking extended-release nifedipine: results of a multicenter, randomized, double-blind, placebo-controlled, parallel-group study. The Zatebradine Study Group.
    Frishman WH; Pepine CJ; Weiss RJ; Baiker WM
    J Am Coll Cardiol; 1995 Aug; 26(2):305-12. PubMed ID: 7608428
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the antianginal efficacy of four calcium antagonists and propranolol in stable angina pectoris.
    Picca M; Azzollini F; Cereda A; Pelosi G
    Eur J Clin Pharmacol; 1989; 37(4):325-31. PubMed ID: 2513206
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of sustained-release diltiazem in stable angina pectoris.
    Weiner DA; Cutler SS; Klein MD
    Am J Cardiol; 1986 Jan; 57(1):6-9. PubMed ID: 3510525
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Randomized double-blind comparison of side effects of nicardipine and nifedipine in angina pectoris. The Nicardipine Investigators Group.
    DeWood MA; Wolbach RA
    Am Heart J; 1990 Feb; 119(2 Pt 2):468-78. PubMed ID: 2405616
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative effects of prolonged therapy with four calcium ion antagonists (diltiazem, nicardipine, tiapamil and verapamil) in patients with chronic stable angina pectoris.
    Khurmi NS; Raftery EB
    Cardiovasc Drugs Ther; 1987; 1(1):81-7. PubMed ID: 3154312
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of nicardipine on chronic stable effort angina: a non-invasive assessment.
    Galderisi M; Celentano A; Mossetti G; Garofalo M; Mureddu GF; Tammaro P; Gravina E; de Divitiis O
    J Int Med Res; 1988; 16(5):349-58. PubMed ID: 3197912
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beneficial effects of high-dose diltiazem in patients with persistent effort angina on beta-blockers and nitrates: a randomized, double-blind, placebo-controlled cross-over study.
    Boden WE; Bough EW; Reichman MJ; Rich VB; Young PM; Korr KS; Shulman RS
    Circulation; 1985 Jun; 71(6):1197-205. PubMed ID: 2859931
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Verapamil administered twice daily in stable angina pectoris.
    Tan AT; Quek S
    Chest; 1984 Jan; 85(1):55-8. PubMed ID: 6360575
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Double-blind efficacy and safety study of a novel anti-ischemic agent, ranolazine, versus placebo in patients with chronic stable angina pectoris. Ranolazine Study Group.
    Thadani U; Ezekowitz M; Fenney L; Chiang YK
    Circulation; 1994 Aug; 90(2):726-34. PubMed ID: 8044941
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of combined alpha and beta adrenoceptor blockade in patients with angina pectoris. A double blind study comparing labetalol with placebo.
    Quyyumi AA; Wright C; Mockus L; Shackell M; Sutton GC; Fox KM
    Br Heart J; 1985 Jan; 53(1):47-52. PubMed ID: 3881105
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparison of nine calcium ion antagonists and propranolol: exercise tolerance, heart rate and ST-segment changes in patients with chronic stable angina pectoris.
    Khurmi NS; Raftery EB
    Eur J Clin Pharmacol; 1987; 32(6):539-48. PubMed ID: 3653222
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combination propranolol and bepridil therapy in stable angina pectoris.
    Frishman WH; Charlap S; Farnham DJ; Sawin HS; Michelson EL; Crawford MH; DiBianco R; Kostis JB; Zellner SR; Michie DD
    Am J Cardiol; 1985 Mar; 55(7):43C-49C. PubMed ID: 3883741
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antianginal efficacy and safety of ivabradine compared with amlodipine in patients with stable effort angina pectoris: a 3-month randomised, double-blind, multicentre, noninferiority trial.
    Ruzyllo W; Tendera M; Ford I; Fox KM
    Drugs; 2007; 67(3):393-405. PubMed ID: 17335297
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of L-carnitine on exercise tolerance in chronic stable angina: a multicenter, double-blind, randomized, placebo controlled crossover study.
    Cherchi A; Lai C; Angelino F; Trucco G; Caponnetto S; Mereto PE; Rosolen G; Manzoli U; Schiavoni G; Reale A
    Int J Clin Pharmacol Ther Toxicol; 1985 Oct; 23(10):569-72. PubMed ID: 3905631
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dose-related haemodynamic effects of nicardipine during rest and exercise and variable anti-anginal effects in patients with chronic stable angina.
    Thomassen AR; Bagger JP; Nielsen TT; Henningsen P
    Eur Heart J; 1987 Mar; 8(3):271-6. PubMed ID: 3582386
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of bepridil in patients with chronic stable angina: results of a multicenter trial.
    Hill JA; O'Brien JT; Alpert JS; Gore JM; Zusman RM; Christensen D; Boucher CA; Vetrovec G; Borer JS; Friedman C
    Circulation; 1985 Jan; 71(1):98-103. PubMed ID: 3880521
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ambulatory monitoring and exercise testing in the evaluation of a new long-acting calcium ion antagonist KB-944 (Fostedil) for the treatment of exertional angina pectoris.
    Khurmi NS; Bowles MJ; O'Hara MJ; Lahiri A; Raftery EB
    Int J Cardiol; 1985 Nov; 9(3):289-302. PubMed ID: 3902675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.